MedTrace Logo

Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy

NCT00715546 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2011-06-22

No results posted yet for this study

Summary

The aim of this study is to determine the safety of the autologous transplantation of adipose-derived stem cells in the treatment of lipodystrophies.

Conditions

  • Lipodystrophy

Interventions

PROCEDURE

autologous transplantation of liposuction material enriched with adipose-derived stem cells

Lipoinjection enriched with adipose-derived stem-cells.

Sponsors & Collaborators

  • Irmandade Santa Casa de Misericórdia de Porto Alegre

    lead OTHER

Principal Investigators

  • Eduardo M. Chem, MD · Irmandade Santa Casa de Misericórdia de Porto Alegre

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2011-08-31
Completion
2011-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715546 on ClinicalTrials.gov